Nelson Dusetti.

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Nelson Dusetti.
Jan 6, 2025, 15:59 | Blog
Nelson Dusetti: Thrilled to visit IRCCS Ospedale San Raffaele
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM, shared a…
Dec 28, 2024, 13:46 | Blog
Nelson Dusetti: Transforming Pancreatic Cancer Treatment in 2024 - MediaMedic
MediaMedic shared a post on LinkedIn: "Dr. Nelson Dusetti: Transforming Pancreatic Cancer Treatment in 2024…
Dec 26, 2024, 06:29 | Insight
A European Project to Better Understand and Treat Pancreatic Cancer
Pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC), is one of the most aggressive and deadly…
Dec 23, 2024, 12:55 | Science
Nelson Dusetti: Our European project on pancreatic cancer
Nelson Dusetti, Research Director at INSERM, shared a post on LinkedIn about a recent article…
Dec 11, 2024, 09:32 | Insight
Nelson Dusetti: Our project COMBAT-PDAC has secured nearly 2 million euros in funding from the EP PerMed
Nelson Dusetti, Research Director at INSERM, shared a post on LinkedIn: "I am thrilled to…
Dec 6, 2024, 05:18 | Insight
Nelson Dusetti: A key step forward in Organoid-Based Drug Screening
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Dec 1, 2024, 21:26 | Blog
Nelson Dusetti: Nicolas Fraunhoffer and Brice Chanez have been awarded funding from Canceropôle Provence-Alpes-Côte d'Azur
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 25, 2024, 13:56 | Blog
Nelson Dusetti: The Second Franco-Argentine collaborative meeting on Pancreatic Cancer
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 23, 2024, 12:15 | Blog
Nelson Dusetti: Wearing the purple ribbon to support everyone affected by Pancreatic Cancer
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 23, 2024, 08:32 | Blog
Nelson Dusetti: Representing CRCM and The Institute Paoli-Calmettes at SAIC
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 10, 2024, 02:00 | Insight
Nelson Dusetti: The applicability of our signatures in predicting treatment sensitivity and resistance in PDAC patients
Nelson Dusetti, Scientific Director of the company Predicting Med(CSO) and Chair of TRANSLATE-IT CRCM, shared an…
Nov 6, 2024, 11:03 | Blog
Nelson Dusetti: Discussing Advancements and foster Argentina-France collaborations in pancreatic cancer research
Nelson Dusetti, Scientific Director at the company Predicting Med (CSO), shared a post on LinkedIn: ''I’m pleased…
Oct 27, 2024, 09:26 | Blog
Nelson Dusetti: Modeling the Intratumoral Dynamics of Pancreatic Cancer to Target Resistant Phenotypes
Nelson Dusetti shared a post on X: ''Modeling the Intratumoral Dynamics of Pancreatic Cancer to…
Oct 22, 2024, 16:07 | Blog
Nelson Dusetti: Franco-Argentine Workshop on Pancreatic Cancer Research
Nelson Dusetti, Chair of TRANSLATE-IT CRCM, shared a post on LinkedIn: "Excited to announce the…
Oct 18, 2024, 15:01 | Blog
Nelson Dusetti: The Institut Choiseul recognises Jean-Baptiste Jaussaud as one of the top 100 economic leaders of tomorrow
Nelson Dusetti shared a post by Jean-Baptiste Jaussaud, CEO Predicting Med, on LinkedIn, adding: "It’s an…
Oct 9, 2024, 09:34 | Blog
Nelson Dusetti: The importance of molecular signatures in the personalization of treatments for PDAC
Nelson Dusetti shared on LinkedIn: "We are pleased to announce the release of our article…
Oct 4, 2024, 16:05 | Blog
Developing 3D organoid models to better understand pancreatic cancer treatment resistence
Nelson Dusetti shared a post by Institute Paoli-Calmettes, on Linkedin: ''We are excited about the…
Sep 17, 2024, 19:39 | Blog
Nelson Dusetti: Is a la carte treatment possible for pancreatic adenocarcinoma?
Nelson Dusetti shared a post on LinkedIn: "Next week, an important event will take place in…
Sep 12, 2024, 17:36 | Insight
Nelson Dusetti: A major advancement in transcriptomic signatures for predicting treatment sensitivity in pancreatic cancer
Nelson Dusetti shared on LinkedIn: "We are thrilled to announce a major advancement in transcriptomic…
Sep 9, 2024, 10:07 | Insight
Nelson Dusetti: Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program
Nelson Dusetti shared on X: “Grateful to Institut National Du Cancer for funding through the PRT-K…
Sep 8, 2024, 14:51 | Blog
Nelson Dusetti: Understanding the cellular mechanisms that drive pancreatic cancer treatment resistance in advanced cases
Nelson Dusetti shared on LinkedIn: "We are deeply grateful to the National Cancer Institute  for awarding…
Sep 5, 2024, 15:09 | Blog
Nelson Dusetti: Promising therapeutic strategies for targeting mitochondrial metabolism in pancreatic cancer cells
Nelson Dusetti shared a post on LinkedIn: "Exciting new research from Pierre Cordelier’s team, which we…
Sep 1, 2024, 08:12 | Insight
Enhancing post - operative treatment for pancreatic ductal adenocarcinoma through AI
Nelson Dusetti posted on X: “We are very grateful to Davide Melisi for the thoughtful…
Aug 30, 2024, 15:30 | Insight
Davide Melisi: Predicting sensitivity to chemotherapeutic treatments in pancreatic cancer with AI
Davide Melisi, Associate Professor of Medical Oncology at University of Verona, shared a post on…
Aug 3, 2024, 12:34 | Blog
Nelson Dusetti: Summary of plenary lectures presented by our team at European Pancreatic Club congress
Nelson Dusetti posted on LinkedIn: "I would like to thank Mayoly Laboratories and the Club…
Jul 24, 2024, 22:22 | Insight
Nelson Dusetti: One of the first publications from the Franco-Argentine Network for Pancreatic Cancer
Nelson Dusetti shared a post on LinkedIn:  "We are thrilled to announce one of the…
Jul 20, 2024, 21:00 | Blog
Nelson Dusetti: We are grateful to INCa for funding our project - NeoPREDICT
Nelson Dusetti shared a post on LinkedIn:  . "We are grateful to INCa for funding…
Jul 13, 2024, 04:51 | Dialogues
ASCO24 Updates: Pancreas-View: AI-Powered Precision Medicine for Pancreatic Cancer Treatment
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jul 3, 2024, 07:07 | Blog
The Pancreatic Cancer Team Marseille at the European Pancreatic Club 2024
Nelson Dusetti, Director of Research at CRCM, shared on LinkedIn: "Proud and happy to have…
Jul 2, 2024, 16:08 | Blog
Nelson Dusetti: Clinic and Digital Personalized Medicine seminar at the University of Corte
Nelson Dusetti, Director of the Translational Research and Innovative Therapies department in Pancreatic Cancer team,…
Jun 22, 2024, 14:12 | Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
All: 31 Posts: 1 - 100
Special Coverage